Behandling og diagnostik af tuberkulose: fremad med små skridt

Translated title of the contribution: [Treatment and diagnostisc of tuberculosis: moving slowly forward.]

Ase Bengård Andersen, Troels Lillebæk, Didi Bang, Julie Prahl

    Research output: Contribution to journalJournal articleResearchpeer-review

    2 Citations (Scopus)

    Abstract

    Development of new drugs for the treatment of drug sensitive and drug resistent tuberculosis is badly needed. Substantial progress has been made in the field and presently six new drug components are in clinical phase I and II trials. Drugs approved for other indications e.g. newer fluoroquinolones and oxazolidinones are also being assessed in human phase II and III trials. Efforts are made to develop easy-to-handle diagnostic tools that will allow early detection of potential MDR or XDR cases. The Xpert RIF/MTB is a prototype of such an invention. At long last the field is moving slowly forward.
    Translated title of the contribution[Treatment and diagnostisc of tuberculosis: moving slowly forward.]
    Original languageDanish
    JournalUgeskrift for Laeger
    Volume173
    Issue number12
    Pages (from-to)897-899
    Number of pages3
    ISSN0041-5782
    Publication statusPublished - 21 Mar 2011

    Cite this